Skip to Content

FRIDAY, 07 NOVEMBER 2025, 00:54

Sport

Sale could revolutionise Sheff Wed – administrator

Yesterday at 22:23 PM, via BBC News

Some of the parties interested in buying Sheffield Wednesday have “significant financial means” that could “revolutionise” the troubled club, says a joint administrator.

Education

Her Research Could Improve Training For Service Dogs

Yesterday at 16:30 PM, via New York Times

“This is a type of science that has an impact that most people could see in their homes,” said Erin Hecht, a canine researcher at Harvard. “Now there’s just no money.”

Science/Tech

Tesla Investors Back Musk’s Trillion Dollar Payday

Yesterday at 23:56 PM, via New York Times

Shareholders approved a plan to grant Mr. Musk shares worth nearly $1 trillion if he meets ambitious goals, including vastly expanding the company’s stock market valuation.

Science/Tech

Amazon is Testing an AI Tool That Automatically Translates Books Into Other Languages

Yesterday at 23:30 PM, via Slashdot

An anonymous reader shares a report: Amazon just introduced an AI tool that will automatically translate books into other languages. The appropriately-named Kindle Translate is being advertised as a resource for authors that self publish on the platform. The company says the tool can translate entire books between English and Spanish and German to English. Amazon promises that more languages...

Science/Tech

OpenAI Races to Quell Concerns Over Its Finances

Yesterday at 23:16 PM, via New York Times

The A.I. company faced pushback after a top executive raised the idea of government aid, amid concerns that the A.I. industry is headed toward a dangerous bubble.

Health

What Scientists Are Learning From Brain Organoids

Yesterday at 21:00 PM, via New York Times

Lab-grown “reductionist replicas” of the human brain are helping scientists understand fetal development and cognitive disorders, including autism. But ethical questions loom.

Health

Obesity Drugs May Drop to as Little as $150 a Month

Yesterday at 19:06 PM, via New York Times

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.